コンチネンスケア（排泄ケア）の市場規模、シェア、動向分析レポート：製品別、バッグ使用別、最終用途別、地域別、セグメント別予測、2023年～2030年

コンチネンスケア（排泄ケア）市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のコンチネンスケア市場規模は、2023年から2030年までのCAGRが5.5%で、2030年までに34億9,000万米ドルに達すると予測されています。

大腸がんや膀胱がん、脳卒中、糖尿病など、さまざまな慢性疾患の有病率が増加しています。技術の進歩、様々な医療や在宅ケアの現場における無菌製品の需要の増加、ライフスタイルの変化、老人人口の増加が市場成長の主な要因です。

高血圧と糖尿病の有病率の上昇は尿失禁（UI）を引き起こす主な要因の一つであり、コンチネンスケア製品の需要を世界的に牽引しています。例えば、WHOが2023年に発表した報告書によると、世界全体で約12億8,000万人が高血圧に苦しんでいます。その結果、関連疾患を患う患者の増加が、コンチネンスケア製品の需要を急増させると予想されます。

米国のコンチネンスケア業界で事業を展開している企業には、コロプラスト、ホリスター・インコーポレイテッド、コンバテック・グループなどがあります。これらの企業は幅広い製品と消耗品を提供し、製品の品質、価格、革新性、流通網などの要因に基づいて競争しています。

コンチネンスケア市場レポートハイライト

• 製品別では、膀胱がん、前立腺がん、膀胱調節障害などの慢性疾患の有病率の増加により、尿道カテーテル分野が2022年の市場シェアを52.5%で占めました。
• 用途別では、糖尿病および糖尿病関連UIの世界の有病率の増加により、糖尿病分野が25.5%のシェアで2022年の市場を独占しました。
• バッグ使用別では、無菌バッグが2022年に64.9％の市場シェアを占め、予測期間中に堅調な成長が見込まれます。
• 在宅ケアおよび患者中心の医療サービスにおけるコンチネンスケア製品の需要増加により、2022年には在宅ケア分野がエンドユーザー市場全体の43.0%を占めました。
• 欧州は、クローン病と潰瘍性大腸炎の罹患率が高いため、2022年には48.5%の最高売上高シェアで世界市場を独占しました。Journal of Crohn's and Colitisによると、欧州の総人口の0.3%がIBDに罹患しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コンチネンスケア市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
• コンチネンスケア市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 コンチネンスケア市場：製品の推定・動向分析

• 定義と範囲
• 製品の市場シェア、2018年と2030年
• セグメントダッシュボード
• 製品別の世界のコンチネンスケア市場の見通し
• 市場規模、予測および動向分析、2023年から2030年まで

第5章 コンチネンスケア市場：用途の推定・動向分析

• 定義と範囲
• 用途の市場シェア、2018年および2030年
• セグメントダッシュボード
• 用途別の世界のコンチネンスケア市場の見通し
• 市場規模、予測および動向分析、2023年から2030年まで

第6章 コンチネンスケア：バッグ使用の推定・動向分析

• 定義と範囲
• バッグ使用の市場シェア、2018年および2030年
• セグメントダッシュボード
• バッグ使用別の世界のコンチネンスケア市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで
  • 無菌
  • 非無菌

第7章 コンチネンスケア：最終用途の推定・動向分析

• 定義と範囲
• 最終用途市場シェア、2018年および2030年
• セグメントダッシュボード
• エンドユース別の世界のコンチネンスケア市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで
  • 在宅ケア
  • 病院
  • その他

第8章 コンチネンスケア市場：地域の推定・動向分析

• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2022年
• 市場応用、予測および動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • フランスとドムトム
  • 英国
  • スペイン
  • イタリア
  • ポルトガル
  • オランダ
  • アイルランド
  • ベルギー
  • スイス
  • デンマーク
  • スウェーデン
  • フィンランド
  • ノルウェー
  • チェコ共和国
  • ロシア連邦
  • ポーランド
  • オーストリア
  • ルーマニア
  • スロバキア
  • スロベニア
  • セルビア
  • ギリシャ
  • トルコ
  • ウクライナ
• アジア太平洋地域
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
  • マレーシア
• ラテンアメリカ
  • ブラジル
  • チリ
  • コロンビア
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2022
  • Coloplast Group
  • Convatec Group PLC
  • Hollister Incorporated
  • B. Braun SE
  • BD
  • Wellspect HealthCare
  • Salts Healthcare Ltd.
  • Welland Medical Ltd.

List of Table

Table 1 List of secondary sources

Table 2 List of abbreviations

Table 3 Examples of comorbidity causing or worsening urinary incontinence in older people:

Table 4 Global continence care market revenue estimates and forecast, by product, 2018 - 2030 (Million)

Table 5 Global continence care market revenue estimates and forecast, by application, 2018 - 2030 (Million)

Table 6 Global continence care market revenue estimates and forecast, by usage, 2018 - 2030 (Million)

Table 7 Global continence care market revenue estimates and forecast, by end-use, 2018 - 2030 (Million)

Table 8 Estimate of the total number of hospitals along with the total number of hospital admissions in the U.S.

List of Figures

• Fig. 1 Continence care market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Segment snapshot (Application & Product)
• Fig. 10 Segment snapshot (End-use)
• Fig. 11 Competitive Landscape
• Fig. 12 Incontinence and ostomy care products market lineage market value, 2022 (USD Billion)
• Fig. 13 Continence care market dynamics
• Fig. 14 Continence care market: Porter's analysis
• Fig. 15 Continence care market: PESTEL analysis
• Fig. 16 Continence care market: by product: Key takeaways
• Fig. 17 Continence care market, by product: Market share, 2022 & 2030
• Fig. 18 Urinary catheters market, 2018 - 2030 (USD Million)
• Fig. 19 Intermittent catheters market, 2018 - 2030 (USD Million)
• Fig. 20 Female intermittent catheters market, 2018 - 2030 (USD Million)
• Fig. 21 Male intermittent catheters market, 2018 - 2030 (USD Million)
• Fig. 22 Intermittent catheter sets market, 2018 - 2030 (USD Million)
• Fig. 23 Female intermittent catheter sets market, 2018 - 2030 (USD Million)
• Fig. 24 Male intermittent catheter sets market, 2018 - 2030 (USD Million)
• Fig. 25 Intermittent catheter dry market, 2018 - 2030 (USD Million)
• Fig. 26 Indwelling foley catheter silicone market, 2018 - 2030 (USD Million)
• Fig. 27 2W market, 2018 - 2030 (USD Million)
• Fig. 28 3W market, 2018 - 2030 (USD Million)
• Fig. 29 Catheter maintenance care market, 2018 - 2030 (USD Million)
• Fig. 30 Urinary bags market, 2018 - 2030 (USD Million)
• Fig. 31 Pediatric urine bags market, 2018 - 2030 (USD Million)
• Fig. 32 Night bags>1.5L market, 2018 - 2030 (USD Million)
• Fig. 33 Sterile market, 2018 - 2030 (USD Million)
• Fig. 34 Non-sterile market, 2018 - 2030 (USD Million)
• Fig. 35 Bag accessories market, 2018 - 2030 (USD Million)
• Fig. 36 Leg urine bags<1.5L market, 2018 - 2030 (USD Million)
• Fig. 37 Sterile market, 2018 - 2030 (USD Million)
• Fig. 38 Non-sterile market, 2018 - 2030 (USD Million)
• Fig. 39 Incontinence and bowel management market, 2018 - 2030 (USD Million)
• Fig. 40 Male external catheters silicone market, 2018 - 2030 (USD Million)
• Fig. 41 Female incontinence device market, 2018 - 2030 (USD Million)
• Fig. 42 Irrigation pump/ transanal irrigation market, 2018 - 2030 (USD Million)
• Fig. 43 Continence care market: by application: Key takeaways
• Fig. 44 Continence care market, by application: Market share, 2022 & 2030
• Fig. 45 Spina bifida market, 2018 - 2030 (USD Million)
• Fig. 46 Spinal cord injury market, 2018 - 2030 (USD Million)
• Fig. 47 Cerebral palsy market, 2018 - 2030 (USD Million)
• Fig. 48 Multiple sclerosis market, 2018 - 2030 (USD Million)
• Fig. 49 Parkinson market, 2018 - 2030 (USD Million)
• Fig. 50 Alzheimer market, 2018 - 2030 (USD Million)
• Fig. 51 Stroke market, 2018 - 2030 (USD Million)
• Fig. 52 Diabetes market, 2018 - 2030 (USD Million)
• Fig. 53 BPH market, 2018 - 2030 (USD Million)
• Fig. 54 Prostate cancer market, 2018 - 2030 (USD Million)
• Fig. 55 Bladder cancer market, 2018 - 2030 (USD Million)
• Fig. 56 Continence care market: by usage: Key takeaways
• Fig. 57 Continence care market, by usage: Market share, 2022 & 2030
• Fig. 58 Sterile bags market, 2018 - 2030 (USD Million)
• Fig. 59 Non-sterile bags market, 2018 - 2030 (USD Million)
• Fig. 60 Continence care market: by end-use: Key takeaways
• Fig. 61 Continence care market, by end-use: Market share, 2022 & 2030
• Fig. 62 Home care settings market, 2018 - 2030 (USD Million)
• Fig. 63 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 64 Others market, 2018 - 2030 (USD Million)
• Fig. 65 Continence care market revenue, by region, 2022 & 2030 (USD Million)
• Fig. 66 Regional marketplace: Key takeaways
• Fig. 67 Regional marketplace: Key takeaways
• Fig. 68 North America continence care market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 U.S. continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Canada continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Central Europe continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Germany continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Western Europe continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 France with DOM TOM continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 UK continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 Spain continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Italy continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Portugal continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Netherlands continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Ireland continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Belgium continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Switzerland continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Norway continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Denmark continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Sweden continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Finland continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Eastern Europe continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Czech Republic continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Russian federation continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Poland continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 101 Austria continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Romania continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 103 Slovakia continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Greece continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 105 Turkey continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Ukraine continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 107 Slovenia continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Serbia continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 109 Asia Pacific continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 110 Key country dynamics
• Fig. 111 Reimbursement procurement process
• Fig. 112 Japan continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 113 Key country dynamics
• Fig. 114 China continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 115 Key country dynamics
• Fig. 116 India continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 117 Key country dynamics
• Fig. 118 Australia continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 119 Key country dynamics
• Fig. 120 South Korea continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 121 Malaysia continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 122 Key country dynamics
• Fig. 123 Thailand continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 124 Latin America continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 125 Key country dynamics
• Fig. 126 Brazil continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 127 Key country dynamics
• Fig. 128 Argentina continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 129 Chile continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 130 Colombia continence care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 131 Key company categorization
• Fig. 132 Global company market share analysis, 2022
• Fig. 133 U.S. Company Market Share Analysis, 2022
• Fig. 134 Canada Company market share analysis, 2022
• Fig. 135 Germany company market share analysis, 2022
• Fig. 136 France company market share analysis, 2022
• Fig. 137 UK company market share analysis, 2022
• Fig. 138 Spain company market share analysis, 2022
• Fig. 139 Italy company market share analysis, 2022
• Fig. 140 Portugal company market share analysis, 2022
• Fig. 141 Netherlands company market share analysis, 2022
• Fig. 142 Ireland company market share analysis, 2022
• Fig. 143 Belgium company market share analysis, 2022
• Fig. 144 Switzerland company market share analysis, 2022
• Fig. 145 Denmark company market share analysis, 2022
• Fig. 146 Sweden company market share analysis, 2022
• Fig. 147 Finland company market share analysis, 2022
• Fig. 148 Norway company market share analysis, 2022
• Fig. 149 Czech Republic company market share analysis, 2022
• Fig. 150 Russian federation company market share analysis, 2022
• Fig. 151 Poland company market share analysis, 2022
• Fig. 152 Austria company market share analysis, 2022
• Fig. 153 Romania company market share analysis, 2022
• Fig. 154 Slovakia company market share analysis, 2022
• Fig. 155 Slovenia company market share analysis, 2022
• Fig. 156 Serbia company market share analysis, 2022
• Fig. 157 Greece company market share analysis, 2022
• Fig. 158 Turkey company market share analysis, 2022
• Fig. 159 Ukraine company market share analysis, 2022
• Fig. 160 Hungary company market share analysis, 2022
• Fig. 161 Australia company market share analysis, 2022
• Fig. 162 Japan company market share analysis, 2022
• Fig. 163 Malaysia company market share analysis, 2022
• Fig. 164 China company market share analysis, 2022
• Fig. 165 India company market share analysis, 2022
• Fig. 166 Thailand company market share analysis, 2022
• Fig. 167 South Korea company market share analysis, 2022
• Fig. 168 Argentina company market share analysis, 2022
• Fig. 169 Brazil company market share analysis, 2022
• Fig. 170 Chile company market share analysis, 2022
• Fig. 171 Colombia company market share analysis, 2022
• Fig. 172 Strategy mapping

Continence Care Market Growth & Trends:

The global continence care market size is anticipated to reach USD 3.49 billion by 2030, with a CAGR of 5.5% from 2023 to 2030 according to a new report by Grand View Research, Inc.. Increasing prevalence of various chronic disorders such as colorectal & bladder cancer, strokes, and diabetes. Growing technological advancements, increasing demand for sterile products in various healthcare and homecare settings, and changes in lifestyles, coupled with the rise in the geriatric population are key contributors to the market growth.

The rising prevalence of hypertension and diabetes is one of the major factors causing Urinary Incontinence (UI), driving the demand for continence care products globally. For instance, according to a report released by the WHO in 2023, approximately 1.28 billion people suffer from hypertension globally. Consequently, the increasing number of patients suffering from associated diseases is expected to surge the demand for continence care products.

Some of the companies operating in the U.S. continence care industry are Coloplast, Hollister Incorporated, and Convatec Group, among others. These companies offer a wide range of products & consumables and compete based on factors such as product quality, pricing, innovation, & distribution networks.

Continence Care Market Report Highlights:

• Based on product, the urinary catheters segment dominated the market in 2022 with a share of 52.5%, owing to the increasing prevalence of chronic diseases, such as bladder cancer, prostate cancer, and bladder control problems
• Based on application, the diabetes segment dominated the market in 2022 with a share of 25.5% owing to the globally increasing prevalence of diabetes and diabetes-associated UI
• Based on bag usage, the sterile segment held the dominant market share of 64.9% in 2022 and is expected to witness robust growth during the forecast period, as sterile bags are essential for avoiding infections and other problems
• The home care settings segment held 43.0% of the overall end-user market in 2022, owing to an increase in demand for continence care products for home care and patient-centric healthcare services
• Europe dominated the global market with the highest revenue share of 48.5% in 2022, owing to the high incidence rate of Crohn's disease & ulcerative colitis in this region. According to the Journal of Crohn's and Colitis, 0.3% of the total population in Europe suffers from IBD

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. Bag usage
  • 1.1.4. End-user
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. Bag usage outlook
  • 2.2.4. End-user outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Continence Care Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of Urinary Incontinence (UI)
    • 3.2.1.2. Growing geriatric population
    • 3.2.1.3. Rapid technological advancements
    • 3.2.1.4. Rise in demand for minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Growing concerns regarding Catheter-Associated Urinary Tract Infection (CAUTI)
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Presence of online platform
    • 3.2.3.2. Increase in the initiatives to raise incontinence awareness worldwide
• 3.3. Continence Care Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Covid-19 Impact Analysis

Chapter 4. Continence Care Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Urinary Catheters
  • 4.1.2. Catheter Maintenance/Care
  • 4.1.3. Urinary Bags
  • 4.1.4. Incontinence and Bowel Management
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Surgical Refractor Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
  • 4.5.1. Urinary Catheters
    • 4.5.1.1. Urinary Catheters market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2. Intermittent Catheters
    • 4.5.1.2.1 Intermittent catheters market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2.2 Female
    • 4.5.1.2.2.1 Female market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2.3 Male
    • 4.5.1.2.3.1 Male market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3. Intermittent Catheter Sets
    • 4.5.1.3.1 Intermittent catheter sets market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3.2 Female
    • 4.5.1.3.2.1 Female market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3.3 Male
    • 4.5.1.3.3.1 Male market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.4 Intermittent Catheters Dry
    • 4.5.1.4.1 Intermittent catheters dry market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5 Indwelling Foley Catheters Silicone
    • 4.5.1.5.1 Indwelling foley catheters silicone market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5.2 2W
    • 4.5.1.5.2.1 2W market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5.3 3W
    • 4.5.1.5.3.1 3W market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Catheter Maintenance/Care
    • 4.5.2.1. Catheter Maintenance/Care market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Urinary Bags
    • 4.5.3.1. Urinary Bags market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.2. Pediatric urine bags
    • 4.5.3.2.1 Pediatric urine bags market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.3. Night bags > 1,5L
    • 4.5.3.3.1 Night bags > 1,5L market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.3.2 Sterile
    • 4.5.3.3.2.1 Sterile market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.3.3 Non-Sterile
    • 4.5.3.3.3.1 Non-Sterile market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.4 Bag accessories
    • 4.5.3.4.1 Bag accessories market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.5 Leg urine bags < 1,5L
    • 4.5.3.5.1 Leg urine bags < 1,5L market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3.5.2 Sterile
    • 4.5.2.5.2.1 Sterile market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.5.3 Non-Sterile
    • 4.5.3.5.3.1 Non-Sterile market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Incontinence and Bowel Management
    • 4.5.4.1. Incontinence and Bowel Management market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4.2. Male external catheters silicone
    • 4.5.4.2.1 Male external catheters silicone market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4.3. Female incontinence device
    • 4.5.4.3.1 Female incontinence device market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4.4. Irrigation pump/Transanal irrigation
    • 4.5.4.4.1 Irrigation pump/Transanal irrigation market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Continence Care Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Diabetes
  • 5.1.2. Strokes
  • 5.1.3. Benign Prostatic Hyperplasia (BPH)
  • 5.1.4. Alzheimer
  • 5.1.5. Cerebral Palsy
  • 5.1.6. Parkinson
  • 5.1.7. Prostate Cancer
  • 5.1.8. Spinal Cord Injury
  • 5.1.9. Bladder Cancer
  • 5.1.10. Multiple Sclerosis
  • 5.1.11. Spina Bifida
  • 5.1.12. Others
• 5.2. Application Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Continence Care Market by Application Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
  • 5.5.1. Diabetes
    • 5.5.1.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Strokes
    • 5.5.2.1. Strokes market estimates and forecast 2018 to 2030 (USD Million
  • 5.5.3. Benign Prostatic Hyperplasia (BPH)
    • 5.5.3.1. Benign Prostatic Hyperplasia (BPH) market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Alzheimer
    • 5.5.4.1. Alzheimer market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Cerebral Palsy)
    • 5.5.5.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.6. Parkinson
    • 5.5.6.1. Parkinson market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.7. Prostate cancer
    • 5.5.7.1. Prostate cancer market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.8. Spinal Cord Injury
    • 5.5.8.1. Spinal cord injury market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.9. Bladder cancer
    • 5.5.9.1. Bladder cancer market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.10. Multiple sclerosis
    • 5.5.10.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.11. Spina Bifida
    • 5.5.11.1. Spina Bifida market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.12. Others
    • 5.5.12.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Continence Care: Bag Usage Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Sterile
  • 6.1.2. Non-Sterile
• 6.2. Bag Usage Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Continence Care Market by Bag Usage Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Sterile
    • 6.5.1.1. Sterile market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Non-Sterile
    • 6.5.2.1. Non-sterile market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Continence Care: End-use Estimates & Trend Analysis

• 7.1. Definitions and Scope
  • 7.1.1. Home Care Settings
  • 7.1.2. Hospitals
  • 7.1.3. Others
• 7.2. End-use Market Share, 2018 & 2030
• 7.3. Segment Dashboard
• 7.4. Global Continence Care Market by End-use Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5.1. Home Care Settings
    • 7.5.1.1. Home care settings market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Hospitals
    • 7.5.2.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Others
    • 7.5.3.1. Others market estimates and forecast 2018 to 2030, (USD Million)

Chapter 8. Continence Care Market: Regional Estimates & Trend Analysis

• 8.1. Regional market share analysis, 2022 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Regional Market Share and Leading Players, 2022
  • 8.4.1. North America
  • 8.4.2. Europe
  • 8.4.3. Asia Pacific
  • 8.4.4. Latin America
  • 8.4.5. Middle East and Africa
• 8.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 8.6. North America
  • 8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 8.6.2. U.S.
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 8.6.3. Canada
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 8.7. Europe
  • 8.7.1. France with DOM-TOM
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive Scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. France with DOM-TOM market estimates and forecasts, 2018 - 2030
  • 8.7.2. UK
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. UK market estimates and forecasts, 2018 - 2030
  • 8.7.3. Spain
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Spain market estimates and forecasts, 2018 - 2030
  • 8.7.4. Italy
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 8.7.5. Portugal
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Portugal market estimates and forecasts, 2018 - 2030
  • 8.7.6. Netherlands
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement scenario
    • 8.7.6.5. Netherlands market estimates and forecasts, 2018 - 2030
  • 8.7.7. Ireland
    • 8.7.7.1. Key country dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory framework
    • 8.7.7.4. Reimbursement scenario
    • 8.7.7.5. Ireland market estimates and forecasts, 2018 - 2030
  • 8.7.8. Belgium
    • 8.7.8.1. Key country dynamics
    • 8.7.8.2. Competitive Scenario
    • 8.7.8.3. Regulatory framework
    • 8.7.8.4. Reimbursement scenario
    • 8.7.8.5. Belgium market estimates and forecasts, 2018 - 2030
  • 8.7.9. Switzerland
    • 8.7.9.1. Key country dynamics
    • 8.7.9.2. Competitive Scenario
    • 8.7.9.3. Regulatory framework
    • 8.7.9.4. Reimbursement scenario
    • 8.7.9.5. Switzerland market estimates and forecasts, 2018 - 2030
  • 8.7.10. Denmark
    • 8.7.10.1. Key country dynamics
    • 8.7.10.2. Competitive Scenario
    • 8.7.10.3. Regulatory framework
    • 8.7.10.4. Reimbursement scenario
    • 8.7.10.5. Denmark market estimates and forecasts, 2018 - 2030
  • 8.7.11. Sweden
    • 8.7.11.1. Key country dynamics
    • 8.7.11.2. Competitive Scenario
    • 8.7.11.3. Regulatory framework
    • 8.7.11.4. Reimbursement scenario
    • 8.7.11.5. Sweden market estimates and forecasts, 2018 - 2030
  • 8.7.12. Finland
    • 8.7.12.1. Key country dynamics
    • 8.7.12.2. Competitive Scenario
    • 8.7.12.3. Regulatory framework
    • 8.7.12.4. Reimbursement scenario
    • 8.7.12.5. Finland market estimates and forecasts, 2018 - 2030
  • 8.7.13. Norway
    • 8.7.13.1. Key country dynamics
    • 8.7.13.2. Competitive Scenario
    • 8.7.13.3. Regulatory framework
    • 8.7.13.4. Reimbursement scenario
    • 8.7.13.5. Norway market estimates and forecasts, 2018 - 2030
  • 8.7.14. Czech Republic
    • 8.7.14.1. Key country dynamics
    • 8.7.14.2. Competitive Scenario
    • 8.7.14.3. Regulatory framework
    • 8.7.14.4. Reimbursement scenario
    • 8.7.14.5. Czech Republic market estimates and forecasts, 2018 - 2030
  • 8.7.15. Russian Federation
    • 8.7.15.1. Key country dynamics
    • 8.7.15.2. Competitive Scenario
    • 8.7.15.3. Regulatory framework
    • 8.7.15.4. Reimbursement scenario
    • 8.7.15.5. Russian Federation market estimates and forecasts, 2018 - 2030
  • 8.7.16. Poland
    • 8.7.16.1. Key country dynamics
    • 8.7.16.2. Competitive Scenario
    • 8.7.16.3. Regulatory framework
    • 8.7.16.4. Reimbursement scenario
    • 8.7.16.5. Poland market estimates and forecasts, 2018 - 2030
  • 8.7.17. Austria
    • 8.7.17.1. Key country dynamics
    • 8.7.17.2. Competitive Scenario
    • 8.7.17.3. Regulatory framework
    • 8.7.17.4. Reimbursement scenario
    • 8.7.17.5. Austria market estimates and forecasts, 2018 - 2030
  • 8.7.18. Romania
    • 8.7.18.1. Key country dynamics
    • 8.7.18.2. Competitive Scenario
    • 8.7.18.3. Regulatory framework
    • 8.7.18.4. Reimbursement scenario
    • 8.7.18.5. Romania market estimates and forecasts, 2018 - 2030
  • 8.7.19. Slovakia
    • 8.7.19.1. Key country dynamics
    • 8.7.19.2. Competitive Scenario
    • 8.7.19.3. Regulatory framework
    • 8.7.19.4. Reimbursement scenario
    • 8.7.19.5. Slovakia market estimates and forecasts, 2018 - 2030
  • 8.7.20. Slovenia
    • 8.7.20.1. Key country dynamics
    • 8.7.20.2. Competitive Scenario
    • 8.7.20.3. Regulatory framework
    • 8.7.20.4. Reimbursement scenario
    • 8.7.20.5. Slovenia market estimates and forecasts, 2018 - 2030
  • 8.7.21. Serbia
    • 8.7.21.1. Key country dynamics
    • 8.7.21.2. Competitive Scenario
    • 8.7.21.3. Regulatory framework
    • 8.7.21.4. Reimbursement scenario
    • 8.7.21.5. Serbia market estimates and forecasts, 2018 - 2030
  • 8.7.22. Greece
    • 8.7.22.1. Key country dynamics
    • 8.7.22.2. Competitive Scenario
    • 8.7.22.3. Regulatory framework
    • 8.7.22.4. Reimbursement scenario
    • 8.7.22.5. Greece market estimates and forecasts, 2018 - 2030
  • 8.7.23. Turkey
    • 8.7.23.1. Key country dynamics
    • 8.7.23.2. Competitive Scenario
    • 8.7.23.3. Regulatory framework
    • 8.7.23.4. Reimbursement scenario
    • 8.7.23.5. Turkey market estimates and forecasts, 2018 - 2030
  • 8.7.24. Ukraine
    • 8.7.24.1. Key country dynamics
    • 8.7.24.2. Competitive Scenario
    • 8.7.24.3. Regulatory framework
    • 8.7.24.4. Reimbursement scenario
    • 8.7.24.5. Ukraine market estimates and forecasts, 2018 - 2030
• 8.8. Asia Pacific
  • 8.8.1. Japan
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive Scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement scenario
    • 8.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 8.8.2. India
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 8.8.3. China
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 8.8.4. South Korea
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 8.8.5. Australia
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 8.8.6. Thailand
    • 8.8.6.1. Key country dynamics
    • 8.8.6.2. Competitive Scenario
    • 8.8.6.3. Regulatory framework
    • 8.8.6.4. Reimbursement scenario
    • 8.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 8.8.7. Malaysia
    • 8.8.7.1. Key country dynamics
    • 8.8.7.2. Competitive Scenario
    • 8.8.7.3. Regulatory framework
    • 8.8.7.4. Reimbursement scenario
    • 8.8.7.5. Thailand market estimates and forecasts, 2018 - 2030
• 8.9. Latin America
  • 8.9.1. Brazil
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive Scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement scenario
    • 8.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 8.9.2. Chile
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive Scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement scenario
    • 8.9.2.5. Chile market estimates and forecasts, 2018 - 2030
  • 8.9.3. Colombia
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive Scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement scenario
    • 8.9.3.5. Colombia market estimates and forecasts, 2018 - 2030
  • 8.9.4. Argentina
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive Scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement scenario
    • 8.9.4.5. Argentina market estimates and forecasts, 2018 - 2030
• 8.10. MEA
  • 8.10.1. South Africa
    • 8.10.1.1. Key country dynamics
    • 8.10.1.2. Competitive Scenario
    • 8.10.1.3. Regulatory framework
    • 8.10.1.4. Reimbursement scenario
    • 8.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 8.10.2. Saudi Arabia
    • 8.10.2.1. Key country dynamics
    • 8.10.2.2. Competitive Scenario
    • 8.10.2.3. Regulatory framework
    • 8.10.2.4. Reimbursement scenario
    • 8.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 8.10.3. UAE
    • 8.10.3.1. Key country dynamics
    • 8.10.3.2. Competitive Scenario
    • 8.10.3.3. Regulatory framework
    • 8.10.3.4. Reimbursement scenario
    • 8.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 8.10.4. Kuwait
    • 8.10.4.1. Key country dynamics
    • 8.10.4.2. Competitive Scenario
    • 8.10.4.3. Regulatory framework
    • 8.10.4.4. Reimbursement scenario
    • 8.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2022
  • 9.3.4. Coloplast Group
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Convatec Group PLC
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Hollister Incorporated
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. B. Braun SE
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. BD
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Wellspect HealthCare
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Salts Healthcare Ltd.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Welland Medical Ltd.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives